← Companies|Janux Ther
JA

Janux Ther

JANX·NASDAQLa Jolla CAFounded 2017100 employees
Mid CapbiotechPublicOncology
Platform: TRACTr BiTE
Market Cap
$2B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (JANX)
Loading JANX stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
JAN-1547JAN-1547Approved4Small MoleculePLK4TNFiMDS
ElrasertibJAN-8530Phase 31Gene TherapyTIGITEZH2iNSCLCCTCL
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)
2025-11-08
Elrasertib Ph3 Readout
CTCL
Past
2027-02-10
JAN-1547 Ph3 Readout
MDS
Ph3 Readout
2027-04-05
JAN-1547 Ph3 Readout
MDS
Ph3 Readout
2029-02-05
JAN-1547 Ph3 Readout
MDS
Ph3 Readout
2029-06-24
JAN-1547 Ph3 Readout
MDS
Ph3 Readout